Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    15383562 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Autologous Dendritic Cell Therapy for Type 1 Diabetes Suppression: A Safety Study
Condition: Type 1 Diabetes
Interventions: Biological: Diabetes-suppressive dendritic cell vaccine;   Biological: control dendritic cells

Study has passed its completion date and status has not been verified in more than two years.